# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cance...
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.17) per share. This is a 51.25 percent increase over losses of ...
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.67) per share. This is a 26.75 percent increase over losses of ...
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow t...
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on c...